A Headache for Cardiologists: Ischemia with Non-Obstructive Disease

Treating patients with functional stress test induced ischemia and non-obstructive coronary artery disease (INOCA) is complex and often frustrating. 

Isquemia con enfermedad NO obstructiva.

The multifactorial nature of this disease in addition to the complex physiopathological relationship between angina and ischemia turn these patients into a real headache for cardiologists.

The CIAO-ISCHEMIA was recently published in Circulation and was designed to describe the natural history of symptoms and ischemia in patients with INOCA.

Patients included in this study are peculiar because they had been excluded from ISCHEMIA randomization for failing to meet the criteria for obstructive coronary artery disease.

They all presented angina and stress-induced wall motion abnormalities. The echocardiographic core laboratory was blinded to symptoms, coronary and the presence of coronary artery disease (CAD). 

The pharmacological treatment was left to physician criteria. Primary end point was the correlation between changes in angina frequency and changes in stress echocardiogram. Predictors were analyzed at one year after changes in symptoms and ischemia. These patients were also compared against those included in the ISCHEMIA trial (the only difference being the presence of obstructive CAD).


Read also: Post COVID-19 Persistent Symptoms: Far More Common than Expected.


Patients with INOCA included in the CIAO were far more often women (66% vs 26%) vs ISCHEMIA patients with obstructive CAD (p<0.001). Despite the latter, ischemia magnitude resulted similar between cohorts (median 4 ischemic segments).

Ischemia and angina symptoms were not correlated in CIAO or ISCHEMIA.

After one year, stress echocardiogram resulted normal in half the CIAO participants, while a quarter continued with severe to moderate stress induced ischemia (≥3 ischemic segments). Angina improved in nearly half of patients (43%) though not necessarily the same who saw improved ischemia. In fact, there was no correlation. 


Read also: AAS vs DAPT post TAVI: Meta-Analysis of Randomized Studies.


These are the inconsistencies between stress symptoms and signs that make INOCA patients so challenging when it comes to treating them.  

Conclusion

Treatment improved ischemia and angina in INOCA patients, even though there was no correlation between both. Stress induced ischemia amounts resulted similar between the CIAO cohort (with no obstructive lesions) and the ISCHEMIA cohort (with obstructive CAD). 

Original Title: Natural History of Patients with Ischemia and No Obstructive Coronary Artery Disease: The CIAO-ISCHEMIA Study.

Reference: Harmony R. Reynolds et al. Circulation. 2021 Jun 1. Online ahead of print. doi: 10.1161/CIRCULATIONAHA.120.046791. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...

ACC 2026 | STEMI-Door To Unload: Unloading with Impella before PCI did not reduce infarct size in anterior STEMI

Anterior ST-segment elevation myocardial infarction (STEMI) remains associated with a high incidence of heart failure and mortality, even in the era of early reperfusion....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...